Acetaminophen 325 MG / butalbital 50 MG Oral Tablet [Tencon] — RxCUI 1483329
RxNorm drug concept · Semantic branded drug
RxCUI 1483329
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1483329
Official nameAcetaminophen 325 MG / butalbital 50 MG Oral Tablet [Tencon]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 325 MG / butalbital 50 MG Oral Tablet [Tencon]; TENCON Tablets 50 MG / 325 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
- Why am I getting acetaminophen through an IV instead of just taking a pill?
- Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
- The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
🕸️ Concept Web — How Acetaminophen 325 MG / butalbital 50 MG Oral Tab... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 325 MG / butalbital 50 MG Oral Tablet [Tencon]
RxCUI 1483329 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Butalbital
19860IN -
Acetaminophen / butalbital
214178MIN
-
Acetaminophen
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Tencon
220211BN
-
Tencon
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / butalbital Oral Tablet
370514SCDF -
Acetaminophen / butalbital Oral Product
1152259SCDG -
Acetaminophen / butalbital Pill
1152260SCDG -
Acetaminophen / butalbital Oral Tablet [Tencon]
1087679SBDF -
Tencon Oral Product
1181444SBDG -
Tencon Pill
1181445SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Acetaminophen / butalbital Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 325 MG / butalbital 50 MG Oral Tablet
197426SCD -
Acetaminophen 325 MG
315263SCDC -
Butalbital 50 MG
317309SCDC -
Acetaminophen 325 MG / butalbital 50 MG [Tencon]
569951SBDC
-
Acetaminophen 325 MG / butalbital 50 MG Oral Tablet
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetaminophen 325 MG / butalbital 50 MG Oral Tablet
SCD · 197426 -
Acetaminophen 325 MG
SCDC · 315263 -
Butalbital 50 MG
SCDC · 317309 -
Acetaminophen / butalbital Oral Tablet
SCDF · 370514 -
Acetaminophen / butalbital Oral Product
SCDG · 1152259 -
Acetaminophen / butalbital Pill
SCDG · 1152260
Brand-Name Concepts
-
Acetaminophen 325 MG / butalbital 50 MG [Tencon]
SBDC · 569951 -
Acetaminophen / butalbital Oral Tablet [Tencon]
SBDF · 1087679 -
Tencon Oral Product
SBDG · 1181444 -
Tencon Pill
SBDG · 1181445 -
Tencon
BN · 220211
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1483329 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 11584-0030-01 | 100 TABLET in 1 BOTTLE, PLASTIC (11584-0030-1) | Tencon | El Dorado Distributors LLC | 2013-10-10 |
Observed labelers:
El Dorado Distributors LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.